Consistent with human OSA, these preliminary data outline the prognostic value of c‐Myc expression in cOSA and highlight the potential role of PLK1 as an antiproliferative therapeutic target for tumours overexpressing c‐Myc. The gene discussed is MYC; the disease is neoplasm.